Drug reference

mirvetuximab

Mosby’s 2024 Nursing Drug Reference

Source: Mosby’s 2024 Nursing Drug Reference
PDF pages: 1410

Review source pages for extracted sections and age labels.

Overview

Names and pronunciation

(mir-ve-tux-i-mab) Elahere

PDF page 1410

Functional class

Func. class.: Antineoplastic

PDF page 1410

Uses

USES: Adults with FRα-positive, platinum-resistant epithelial ovarian, fal- lopian tube, or primary peritoneal can- cer who have received 1-3 prior systemic regimens

PDF page 1410

Dose and formulations

Dosage and routes

DOSAGE AND ROUTES Adult: IV INF 6 mg/kg q3wk until dis- ease progression or unacceptable toxic- ity; premedicate with a corticosteroid, antihistamine, and antipyretic; anti- emetic; ophthalmic topical steroids; and lubricating eye drops

PDF page 1410

Available forms

Available forms: Injection: 100 mg/20 mL (5 mg/mL) in a single-dose vial

PDF page 1410

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.

Drug reference

mirvetuximab

Mosby’s 2024 Nursing Drug Reference

Source: Mosby’s 2024 Nursing Drug Reference
PDF pages: 1410

Review source pages for extracted sections and age labels.

Overview

Names and pronunciation

(mir-ve-tux-i-mab) Elahere

PDF page 1410

Functional class

Func. class.: Antineoplastic

PDF page 1410

Uses

USES: Adults with FRα-positive, platinum-resistant epithelial ovarian, fal- lopian tube, or primary peritoneal can- cer who have received 1-3 prior systemic regimens

PDF page 1410

Dose and formulations

Dosage and routes

PDF page 1410

Available forms

Available forms: Injection: 100 mg/20 mL (5 mg/mL) in a single-dose vial

PDF page 1410

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.